Abstract
Metachromatic leukodystrophy (MLD) is an autosomal recessive progressive demyelinating disorder. Its incidence is estimated to be between 1:40 000 and 1:130 000. The disease can be divided into three different subtypes: the late infantile, the juvenile and the adult variant. This subdivision is based on the age of onset, the duration, and the clinical picture of the disease. Within one family only one variant of MLD occurs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ameen M, Chang PL (1987) Pseudo arylsulfatase A deficiency: biosynthesis of an abnormal arylsulfatase A. FEBS Lett 219: 130–134
Ameen M, Lazzarino DA, Kelly BM, Gabel CA, Chang PL (1990) Deficient glycosylation of arylsulfatase A in pseudo arylsulfatase-A deficiency. Mol Cell Biochem 92: 117–127
Aurebeck G, Osterberg K, Blaw M, Chou S, Nelson E (1964) Electron microscopic observations on metachromatic leukodystrophy. Arch Neurol 11: 273–288
Austin J, McAfee D, Armstrong D, ORourke M, Shearer L, Bachhawat B (1964) Low sulfatase activities in metachromatic leukodystrophy ( MLD ). Trans Am Neurol Assoc 89: 147–150
Bass NH, Witmer J, Dreifuss FE (1970) A pedigree study of metachromatic leukodystrophy. Neurology 20: 52–62
Baumann N, Masson M, Carreau V, Lefevre M, Herschkowitz N, Turpin JC (1991) Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Dev Neurosci 13: 211–215
Bohne W, Figura von K, Gieselmann V (1991) An 11-bp deletion in the arylsulfatase A gene of a patient with late infantile metachromatic leukodystrophy. Hum Genet 87: 155–158
Clarke JTR, Skomorowski MA, Chang PL (1989) Marked clinical difference between two sibs affected with juvenile metachromatic leukodystrophy. Am J Med Genet 33: 10–13
Dayan AD (1967) Peripheral neuropathy of metachromatic leucodystrophy: observations on segmental demyelination and remyelination and the intracellular distribution of sulphatide. J Neurol Neurosurg Psychiatry 30: 311–318
Dayan AD, Marsh J, Jackson M, McGuire VM, Vimal C, Nicolaides K, Sheridan R (1988) First-trimester diagnosis of metachromatic leucodystrophy. Clin Genet 34: 122–125
Fluharty AL, Fluharty CB, Bohne W, von Figura K, Gieselmann V (1991) Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy ( MLD) patient. Am J Hum Genet 49: 1340–1350
Francis GS, Bonni A, Shen N, Hechtman P, Yamut B, Carpenter S, Karpati G, Chang PL (1993) Metachromatic Leukodystrophy: multiple nonfunctional and pseudodeficiency alleles in a pedigree: problems with diagnosis and counseling. Ann Neurol 34: 212–218
Fressinaud C, Vallat JM, Masson M, Jauberteau MO, Baumann N, Hugon J (1992) Adult-onset metachromatic leukodystrophy presenting as isolated peripheral neuropathy. Neurology 42: 1396–1398
Fukumizu M, Matsui K, Hanaoka S, Sakutagawa N, Kurokawa T (1992) Partial seizures in two cases of metachromatic leukodystrophy:electrophysiologic and neuroradiologic findings. J Child Neurol 7: 381–386
Fullerton PM (1964) Peripheral nerve conduction in metachromatic leucodystrophy (sulphatide lipidosis). J Neurol Neurosurg Psychiatry 27: 100–105
Gieselmann V (1991) An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counselinf for metachromatic leukodystrophy. Hum Genet 86: 251–255
Gieselmann V, Polten A, Kreysing J, von Figura K (1989) Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA 86: 9436–9440
Gieselmann V, Fluharty AL, Tonnesen T, von Figura K (1991a) Mutations in the arylsulfatase A pseudodeficiency allele causing metachromatic leukodystrophy. Am J Hum Genet 49: 407–413
Gieselmann V, Polten A, Kreysing J, Kappler J, Fluharty A, Bohne W, von Figura K (1991b) Mutations in arylsulfatase A alleles causing metachromatic leukodystrophy. Brain Dysfunct 4: 235–243
Gieselmann V, Polten A, Kreysing J, Kappler J, Fluharty A, von Figura K (1991c) Molecular genetics of metachromatic leukodystrophy. Dev Neurosci 13: 222–227
Gieselmann V, Polten A, Kreysing J, von Figura K (1994) Molecular genetics of metachromatic leukodystrophy. J Inherited Metab Dis 17: 500–509
Ginsberg L, Gershfeld NL (1991) Membrane bilayer instability and the pathogenesis of disorders of myelin. Neurosci Lett 130: 133–136
Grégoire A, Périer O, Dustin P (1966) Metachromatic leukodystrophy, an electron microscopic study. J Neuropathol Exp Neurol 25: 617–636
Hagberg B (1963) Clinical symptoms, signs and tests in metachromatic leukodystrophy. In: Folch-Pi J, Bauer H (eds) Brain lipids and lipoproteins and the leukodystrophies. Elsevier, Amsterdam, pp 134–146
Haltia T, Palo J, Haltia M, Icen A (1980) Juvenile metachromatic leukodystrophy:clinical, biochemical, and neuro-pathologic studies in nine new cases. Arch Neurol 37: 42–46
Hohenschutz C, Friedl W, Schlör KH, Waheed A, Conzelmann E, Sandhoff K, Propping P (1988) Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology. Am J Med Genet 31: 169–175
Holtschmidt H, Sandhoff K, Kwon HY, Harzer K, Nakano T, Suzuki K (1991) Sulfatide activator protein. J Biol Chem 266: 7556–7560
Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in metachromatic leukodystrophy: Insights into the neurobiology of psychosis. Arch Neurol 49: 401–406
Inui K, Furukawa M, Nishimoto J, Okada S, Yabuuchi H (1987) Metabolism of cerebroside sulphate and subcellular distribution of its metabolites in cultured skin fibroblasts derived from controls, metachromatic leukodystrophy, globoid cell leukodystrophy and Farber disease. J Inherited Metab Dis 10: 293–296
Inui K, Furukawa M, Okada S, Yabuuchi H (1988) Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoic cell leukodystrophy. J Clin Invest 81: 310–317
Jayakumar PN, Aroor SR, Jha RK, Arya BYT (1989) Computed tomography ( CT) in late infantile metachromatic leucodystrophy. Acta Neurol Scand 79: 23–26
Jervis GA (1960) Infantile metachromatic leukodystrophy. J Neuropathol Exp Neurol 19: 323–340
Kappler J, Watts RWE, Conzelmann E, Gibbs DA, Propping P, Gieselmann V (1991) Low arylsulphatase A activity and choreoathetotic syndrome in three siblings: differentiation of pseudodeficiency from metachromatic leukodystrophy. Eur J Pediatr 150: 287–290
Kappler J, von Figura K, Gieselmann V (1992) Late-onset metachromatic leukodystrophy:molecular pathology in two siblings. Ann Neurol 31: 256–261
Kondo R, Wakamatsu N, Yoshino H, Fukuhara N, Miyatake T, Tsuji S (1991) Identification of a mutation in the arylsulfatase A gene of a patient with adult-type metachromatic leukodystrophy. Am J Hum Genet 48: 971–978
Kreysing J, von Figura K, Gieselmann V (1990) Structure of the arylsulfatase A gene. Eur J Biochem 191: 627–631
Krivit W, Shapiro E, Kennedy W, Lipton M, Lockman L, Smith S, Gail Summers C, Wenger DA, Tsai MY, Ramsay NKC, Kersey JH, Yao JK, Kaye E (1990) Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med 322: 28–32
Krivit W, Shapiro E, Hoogerbrugge PM, Moser HW (1992) State of the art review:bone marrow transplantation treatment for storage diseases. Bone Marrow Transpl 10 Supp 11: 87–96
Leroy JG, von Eisen AF, Martin JJ, Dumon JE, Hulet AE, Okada S, Navarro C (1973) Infantile metachromatic leukodystrophy. N Engl J Med 288: 1365–1369
Li ZG, Waye JS, Chang PL (1992) Diagnosis of arylsulfatase A deficiency. Am J Med Genet 43: 976–982
McKhann GM (1984) Metachromatic leukodystrophy: clinical and enzymatic parameters. Neuropediatrics 15: 4–10
Mei Liu H (1968) Ultrastructure of central nervous system lesions in metachromatic leuko dystrophy with special reference to morphogenesis. J Neuropathol Exp Neurol 27: 624644
Norman RM, Urich H, Tingey AH (1960) Metachromatic leuco-encephalopathy: a form of lipidosis. Brain 83: 369380
Norton WT, Cammer W (1984) Chemical pathology of diseases involving myelin. In: Morell P (ed) Myelin. Plenum, New York, pp 369–403
Olsson Y, Sourander P (1969) The reliability of the diagnosis of metachromatic leucodystrophy by peripheral nerve biopsy. Acta Paediatr Scand 58: 15–24
Penzien JM, Kappler J, Herschkowitz N, Schuknecht B, Keinekugel P, Propping P, Tonnesen T, Lou H, Moser H, Zierz S, Conzelmann E, Gieselmann V (1993) Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease. Am J Hum Genet 52: 557–564
Poenaru L, Castelnau L, Besancon AM, Nicolesco H, Akli S, Theophil D (1988) First trimester prenatal diagnosis of metachromatic leukodystrophy on chorionic villi by immunoprecipitation–electrophoresis. J Inherited Metab Dis 11: 123–130
Polten A, Fluharty AL, Fluharty CB, Kappler J, von Figura K, Gieselmann V (1991) Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324: 1822
Rafi MA, Zhang X, de Gala G, Wenger DA (1990) Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a cariant form of metachromatic leukodystrophy. Biochem Biophys Res Commun 166: 1017–1023
Rafi MA, Amini S, Zhang X, Wenger DA (1992) Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-I deficiency. Am J Hum Genet 50: 1252–1258
Reider-Grosswasser I, Bornstein N (1987) CT and MRI in late-onset metachromatic leukodystrophy. Acta Neurol Scand 75: 64–69
Résibois-Grégoire A (1967) Electron microscopic studies of metachromatic leucodystrophy II. Compound nature of the inclusions. Acta Neuropathol 9: 244–253
Rommerskirch W, Fluharty AL, Peters C, von Figura K, Gieselmann (1991) Restoration of arylsulphatase A activity in human-metachromatic-leucodystrophy fibroblasts via retroviral-vector-mediated gene transfer. Biochem J 280: 459–461
Schipper HI, Seidel D (1984) Computed tomography in late-onset metachromatic leucodystrophy. Neuroradiology 26: 39–44
Schlote W, Harzer K, Christomanou H, Paton BC, KustermannB, Schmid B, Seeger J, Beudt U, Schuster I, Langen-beck U (1991) Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur J Pediatr 150: 584–591
Scholz W (1925) Klinische, pathologisch-anatomische and erbbiologische Untersuchungen. Z Neurol Psychiatr 99: 651717
Shapiro EG, Lipton ME, Krivit W (1992) White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant. J Clin Exp Neuropsychol 14: 610–624
Skomer C, Stears J, Austin J (1983) Metachromatic leukodystrophy ( MLD ). Arch Neurol 40: 354–355
Slavin S, Naparstek E, Ziegler M, Lewin A (1992) Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases–feasibility studies. Bone Marrow Transplant 9 Suppl 11: 189–190
Stevens RL, Fluharty AL, Kihara H, Kaback MM, Shapiro LJ, Marsh B, Sandhoff K, Fischer G (1981) Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet 33: 900–906
Toda K, Kobayashi T, Goto I, Kurokawa T, Ogomori K (1989) Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy. Biochem Biophys Res Commun 159: 605–611
Waltz G, Harik SI, Kaufman B (1987) Adult metachromatic leukodystrophy: value of computed tomographic scanning and magnetic resonance imaging of the brain. Arch Neurol 44: 225–227
Wenger DA, Louie E (1991) Pseudodeficiencies of arylsulfatase A and galactocerebrosidase activities. Dev Neurosci 13: 216221
Wright GDS, Patel MK, Mikel J (1988) An adult onset metachromatic leukodystrophy with dominant inheritance and normal arylsulphatase A levels. J Neurol Sci 87: 153–166
Zhang XL, Rafi MA, DeGala G, Wenger DA (1990) Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc Natl Acad Sci USA 87: 1426–1430
Zhang X, Rafi MA, Gala de G, Wenger DA (1991) The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum Genet 87: 211–215
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
van der Knaap, M.S., Valk, J. (1995). Metachromatic Leukodystrophy. In: Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03078-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-03078-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03080-6
Online ISBN: 978-3-662-03078-3
eBook Packages: Springer Book Archive